Pharmacyclics, Inc. (PCYC) Posts Q2 Loss of 26c/Share
Tweet
Share
E-mailGet Alerts PCYC Hot Sheet
Price: $261.25 --0%
Financial Fact:
Other (expense) income, net: 285K
Today's EPS Names:
DTGI, OCCI, MAYS, More
Financial Fact:
Other (expense) income, net: 285K
Today's EPS Names:
DTGI, OCCI, MAYS, More
Join SI Premium – FREE
Pharmacyclics, Inc. (NASDAQ: PCYC) reported Q2 EPS of ($0.26), $0.03 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $113 million versus the consensus estimate of $95.88 million.
For earnings history and earnings-related data on Pharmacyclics, Inc. (PCYC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
- InTest joins Russell 2000 and Russell 3000 indexes
- Genco Shipping & Trading Limited Responds to Diana Shipping Extending its Inadequate $24.80 Unsolicited Tender Offer
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
